Pharmacyte Biotech Inc  

(Public, OTCMKTS:PMCB)   Watch this stock  
+0.0005 (0.76%)
Aug 18 - Close
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 0.06 - 0.07
52 week 0.02 - 0.17
Open 0.06
Vol / Avg. 614,337.00/1.85M
Mkt cap 64.23M
P/E     -
Div/yield     -
EPS -0.01
Shares 973.17M
Beta 2.71
Inst. own 0%

Key stats and ratios

Q2 (Apr '17) 2017
Net profit margin - -
Operating margin - -
EBITD margin - -
Return on average assets -56.91% -56.15%
Return on average equity -61.26% -60.83%
Employees 4 -
CDP Score - -


23046 Avenida de La Carlota Ste 600
LAGUNA HILLS, CA 92653-1537
United States - Map
+1-917-5952850 (Phone)
+1-917-5952851 (Fax)

Website links


PharmaCyte Biotech, Inc., formerly Nuvilex, Inc., is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes based upon a cellulose-based live cell encapsulation technology known as Cell-in-a-Box. The Company's Cell-in-a-Box technology will be used as a platform upon which treatments for various types of cancer, including advanced, inoperable pancreatic cancer, and diabetes will be developed. The Company is developing therapies for pancreatic and other solid cancerous tumors involving the encapsulation of live cells placed in the body to enable the delivery of cancer-killing drugs at the source of the cancer. It is also developing a therapy for Type I diabetes and insulin-dependent Type II diabetes based upon the encapsulation of a human cell line genetically engineered to produce, store and secrete insulin at levels in proportion to the levels of blood sugar in the human body using its Cell-in-a-Box technology.

Officers and directors

Kenneth L. Waggoner JD Chairman of the Board, President, Chief Executive Officer, General Counsel
Age: 67
Gerald W. Crabtree Ph.D. Chief Operating Officer, Director
Age: 74
Walter H. Gunzburg Chief Scientific Officer
Michael M. Abecassis M.D. Director
Richard M. Goldfarb M.D. Director
Age: 61
Thomas Liquard Director
Age: 43
Thomas C. K. Yuen Director
Age: 62